Using a comprehensive proteomic approach, paired with the molecular characterization of FUT8 in prostate cancer cells, we were able to identify mechanisms in which prostate cancer cells alter and modify cellular proteins which help overcome steroid-dependent hormone signaling through cell surface receptors via hyper-glycosylation. This evidence concerns the gene CD177 and prostate cancer.